Azithromycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70436-019

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Azithromycin (NDC 70436-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Slate Run Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

FDA Label Image

T:\spl Documents\azithromycin Injection\spl\label-500mg V3.0 Cropped.jpg (Image 02)

T:\spl Documents\azithromycin Injection\spl\label-500mg V3.0 Cropped.jpg (Image 02)
This is a prescription drug labeled as NDC 70436-019-82 with dosing and usage information available in the accompanying prescribing information. It is an intravenous infusion that should be diluted before use with sterile water for injection. Each vial contains 100mg of azithromycin dihydrate, equivalent to 500mg of azithromycin. The drug requires adjustment of pH levels using citric acid and sodium hydroxide, and each vial contains 114 mg of sodium. The manufacturer of the drug is Slate Run Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.